期刊文献+

慢性乙型肝炎抗病毒治疗依从性影响因素分析 被引量:12

Analysis on influence factors of antiviral therapy compliance in chronic hepatitis B cases
原文传递
导出
摘要 目的探讨慢性乙型病毒性肝炎患者用药依从性的影响因素。方法以服药依从性差的32例患者为观察组;服药依从性好的32例患者为对照组。采用Logistic回归分析方法,探索影响慢性乙型肝炎患者服药依从性的因素。结果与服药依从性差的患者相比,服药依从性好的患者组中有乙肝家族史(OR0.042,95%C.I.0.005~0.333)、抗病毒治疗的认知程度高(OR 0.112,95%C.I.0.014~0.872)和“医师告知”详细(OR0.142,95%C.I.0.020~0.993)的出现服药依从性差的危险度均降低。结论有乙肝家族史的患者,可从亲属的诊疗经历中获得经验,而服药依从性较好。此外,医师加强对患者“治疗认知度”的培训,可提高患者抗病毒治疗的依从性。 Objective To analyze the factors which influenced medication compliance of patients with chronic hepatitis B (CHB), so as to improve the treatment compliance of patients. Methods 32 pa- tients with poor compliance were recruited as the observation group, 32 patients with good compliance were selected as the control group. The multivariate logistic regression model was used to investigate the potential correlative factors that influenced the medication compliance of the case. Results Compared with poor med- ication compliance of patients, the good medication compliance of patients, who had family history of hepati- tis B (OR 0. 042, 95% CI 0. 005-0. 333 ) , learned more about the content of the antiviral treatment (OR 0. 112, 95% CI 0. 014-0. 872) , and got more information from physicians ( OR 0. 142, 95% CI 0. 020- 0. 993 ) , showed poor compliance risk reduction. Conclusions The patients who had family history of hep- atitis B can gain more message from the relative experience of treatment. Their medication compliance were better. Future work should focus on health education to improve the compliance of patients receiving antiviral therapy.
出处 《国际病毒学杂志》 2014年第3期126-128,共3页 International Journal of Virology
关键词 慢性乙型病毒性肝炎 抗病毒治疗 治疗认知度 依从性 Chronic viral hepatitis B Antiviral therapy Treatment of cognition Compliance
  • 相关文献

参考文献5

二级参考文献35

共引文献833

同被引文献124

  • 1杨玉凤,杨丽翠,尹利华.慢性乙型病毒性肝炎患者生活方式依从性现状[J].解放军护理杂志,2009,26(16):27-29. 被引量:4
  • 2段淑红,鲍中英,苑晓冬,刘梅生,王蕾,晓明.核苷类似物治疗慢性乙型肝炎持续或间断服用与肝癌发生的相关性[J].中华肝脏病杂志,2014,22(6). 被引量:1
  • 3王晓军,张荣珍,胡苑笙,梁晓峰.我国病毒性肝炎流行现状研究[J].疾病监测,2004,19(8):290-292. 被引量:150
  • 4张南,王宇明,邓国宏,易东.慢性重型肝炎患者的预后因素分析及预后模型的建立[J].中华肝脏病杂志,2005,13(10):730-733. 被引量:32
  • 5中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝脏病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].中华临床感染病杂志,2012,5(6):321-327.
  • 6Liu CT, Chen TH, Cheng CY. Successful treatment of drag-in- duced acute liver failure with high-volume plasma exchange [ J ]. J Clin Apher, 2013, 28 (6) : 430434.
  • 7Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure [ J ]. Best Pract Res Clin Gastroenterol, 2012, 26(1) : 17-26.
  • 8Ryan JM, Tranah T, Mitry RR, et al. Acute liver failure in Ja- pan : definition, classification, and prediction of the outcome [ J ]. J Gastroenterol, 2012, 47 (8) : 849-861.
  • 9Rocen M, Kieslichova E, Merta D, et al. The effect of prome- theus device on laboratory markers of inflammation and tissue re- generation in acute liver failure management [ J ]. Transplant Proc, 2010,42(9) : 3606-3611.
  • 10Banares R, Catalina MV, Vaquero J. Liver support systems : will they ever reach prime time? [ J]. Curr Gastroenterol Rep, 2013, 15(3): 312.

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部